Skip to main content
. 2011 Feb 1;52(3):387–395. doi: 10.1093/cid/ciq111

Table 2.

Baseline Laboratory Values among Patients Starting Commonly Prescribed Statins (N = 678)

Atorvastatin
Pravastatin
Rosuvastatin
Mean SD Mean SD Mean SD P
Total cholesterol, mg/dL 239 56 240 58 219 38 .004
LDL-C, mg/dL 140 36 141 40 134 30 .3
Triglyceride, mg/dL 373 375 322 244 310 238 .08
HDL-C, mg/dL 38 10 40 14 40 12 .1
BMI, kg/m2 27 5 27 6 26 5 .3
AST,a U/L 30 18 34 27 32 21 .2
ALT,a U/L 36 27 39 44 33 21 .2
Creatinine,b mg/dL 1.0 .3 1.1 .8 1.1 .3 .2
Glucose,c mg/dL 105 49 106 51 106 53 .9

NOTE. Comparisons between statins were made using 1-way analyses of variance. To convert total cholesterol, LDL-C, non-HDL-C, or HDL-C values to mmol/L, multiply by .0259. To convert triglyceride values to mmol/L, multiply by .0113. ALT alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; SD, standard deviation.

a

Baseline AST and ALT data available on 664 patients. Data available from a median of 2 d before starting therapy (interquartile range, 0– 21 d).

b

Baseline creatinine data available on 676 patients. Data available from a median of 13 d before starting therapy (interquartile range, 0– 36 d).

c

Baseline glucose data available on 675 patients. Data available from a median of 19 d before starting therapy (interquartile range, 0– 91 d).